Product Code: A11273
The global elastography imaging market was valued at $3,019.01 million in 2021 and is projected to reach $6,002.4 million by 2031, registering a CAGR of 7.1% from 2022 to 2031. Elastography is a medical imaging modality or system that plans the elastic properties and stiffness of mainly soft tissue. The system is used to identify whether the tissue is hard or soft and hence give diagnostic information regarding the presence or status of the disease. For instance, cancerous tumors will often be harder than the surrounding tissue, and diseased livers are stiffer than healthy ones. The most widely used techniques utilize ultrasound or magnetic resonance imaging (MRI) to make both the stiffness map and an anatomical image for comparison. Elastography measures the stiffness (or elasticity) of organs in vivo by using low-frequency vibrations during an ultrasound or MRI. It is mainly used for detecting the presence and severity of liver disease.
Magnetic resonance elastography (MRE) is a technology that combines MRI imaging with low-frequency vibrations to create a visual map (elastogram) that shows the stiffness of body tissues. Currently, MRE is used to detect stiffening of the liver caused by fibrosis and inflammation in chronic liver disease.
As patient volumes continue to increase due to ageing populations and increasing co-morbidities, and budgets continue to shrink; it is evident that the elastography imaging market is in a unique position to grow due to its cost-effective, real-time, portable solutions.
The key factors that drive the growth of the market are the rise in incidence of breast cancer, and chronic liver diseases, and the surge in the demand for minimally invasive procedures, or non-invasive techniques for cancer detection and treatment. For instance, according to the article published by the American Association for the Study of Liver Disease, the absolute number of chronic liver disease (CLD) cases is estimated at 1.5 billion worldwide in 2021. The most common causes of prevalent disease are non-alcoholic fatty liver disease (NAFLD) (59%), followed by hepatitis B virus (HBV) (29%), hepatitis C virus (HCV) (9%), and ALD (2%). Moreover, there are 257 million people worldwide living with chronic HBV. Without proper management, approximately 20% will die early of liver failure or hepatocellular carcinoma. It is estimated that only 11% of infected people are aware of their infection, and 17% of those are receiving treatment.
Furthermore, product advancements and new launches are projected to assist key leaders in gaining maximum market share as they have focused on meeting market demand. High quality transducers, reduced diagnosis time, and effective usage in point-of-care and remote diagnosis are expected to fuel market growth. For instance, Royal Philips, a global leader in health technology, launched new AI-enabled innovations in MR imaging at the Radiological Society of North America (RSNA) annual meeting in November 2021. Philips' new MR portfolio of intelligent integrated solutions is designed to speed up MR exams, streamline workflows, optimize diagnostic quality, and help ensure the efficiency and sustainability of radiology operations.
However, higher cost of the elastography imaging systems is anticipated to hinder the growth of the industry during the forecast period. Conversely, the emerging healthcare market in developing countries and low-income countries lacking access to basic healthcare and, alternatively, the use of elastography imaging for cancer research is anticipated to generate new growth opportunities in the elastography imaging market during the forecast time period.
The elastography imaging market is segmented on the basis of modality, application, end user and region. By modality, the market is bifurcated into ultrasound elastography imaging and magnetic resonance elastography. On the basis of application, the market is classified into radiology/general imaging, obstetrics/gynecology, cardiology, urology, vascular and other. By end user, the market is categorized into hospitals & clinics, diagnostic labs, maternity centers, ambulatory surgical centers and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By modality, on the basis of ultrasound elastography imaging, the market is further sub-segmented into shear-wave elastography, strain elastography, 1D transient elastography.
- North America accounted for a majority of the elastography imaging market share in 2021 and is anticipated to remain dominant during the forecast period. The elastography imaging market is mainly driven by the increase in chronic diseases and cancer incidences, rise in the healthcare expenditure of this region, presence of key players in the country, and the strategies they adopt for their product development.
- Asia-Pacific was the second largest contributor to the market in 2021 and is expected to register the fastest CAGR during the forecast period. This is due to the presence of high unmet medical needs and constantly improving healthcare infrastructure to cure chronic disorders. In addition, rapidly growing prevalence of breast cancer and liver disease, surge in the demand for minimally invasive or non-invasive procedures, and increase in geriatric population in emerging nations are set to drive the growth of the market in Asia-Pacific region. This helps several market players to invest in Asia-Pacific countries, which in turn is projected to further contribute toward the growth of the market.
- The key players that operate in the Elastography imaging market are Canon Medical System Corporation, Clarius Mobile Health, Esaote Spa, Fujifim Sonosite Inc, General Electric Company, Hitachi Ltd, Hologic, Koninklijke Philips, Mindray Medical Corporation, Siemens AG.
- Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the elastography imaging market analysis from 2021 to 2031 to identify the prevailing elastography imaging market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the elastography imaging market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global elastography imaging market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End User
- Hospitals and Clinics
- Diagnostic labs
- Maternity Centers
- Ambulatory Surgical Centers
- Others
By Modality
- Magnetic Resonance Elastography
- Ultrasound Elastography Imaging
- Type
- Shear-Wave Elastography
- Strain Elastography
- 1D transient Elastography
By Application
- Radiology/General Imaging
- Cardiology
- Obstetrics/Gynecology
- Urology
- Vascular
- Others
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
- Key Market Players
- Esaote SpA
- Shenzhen Mindray Bio-Medical Electronics Co
- Clarius Mobile Health
- Hitachi,Ltd
- Fujifilm Corporation
- Canon Inc
- Koninklijke Philips N.V.
- GE
- Siemens Healthineers
- Hologic Inc
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ELASTOGRAPHY IMAGING MARKET, BY MODALITY
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Ultrasound Elastography Imaging
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Ultrasound Elastography Imaging Elastography Imaging Market by Type
- 4.2.4.1 Shear-Wave Elastography Market size and forecast, by region
- 4.2.4.2 Strain Elastography Market size and forecast, by region
- 4.2.4.3 1D transient Elastography Market size and forecast, by region
- 4.3 Magnetic Resonance Elastography
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
CHAPTER 5: ELASTOGRAPHY IMAGING MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Radiology/General Imaging
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Cardiology
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Obstetrics/Gynecology
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Urology
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- 5.6 Vascular
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
- 5.7 Others
- 5.7.1 Key market trends, growth factors and opportunities
- 5.7.2 Market size and forecast, by region
- 5.7.3 Market analysis by country
CHAPTER 6: ELASTOGRAPHY IMAGING MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals and Clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Diagnostic labs
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Maternity Centers
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Ambulatory Surgical Centers
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- 6.6 Others
- 6.6.1 Key market trends, growth factors and opportunities
- 6.6.2 Market size and forecast, by region
- 6.6.3 Market analysis by country
CHAPTER 7: ELASTOGRAPHY IMAGING MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Modality
- 7.2.2.1 North America Ultrasound Elastography Imaging Elastography Imaging Market by Type
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Modality
- 7.2.5.1.2 Market size and forecast, by Application
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Modality
- 7.2.5.2.2 Market size and forecast, by Application
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Modality
- 7.2.5.3.2 Market size and forecast, by Application
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Modality
- 7.3.2.1 Europe Ultrasound Elastography Imaging Elastography Imaging Market by Type
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Modality
- 7.3.5.1.2 Market size and forecast, by Application
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Modality
- 7.3.5.2.2 Market size and forecast, by Application
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Modality
- 7.3.5.3.2 Market size and forecast, by Application
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Modality
- 7.3.5.4.2 Market size and forecast, by Application
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Modality
- 7.3.5.5.2 Market size and forecast, by Application
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Modality
- 7.3.5.6.2 Market size and forecast, by Application
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Modality
- 7.4.2.1 Asia-Pacific Ultrasound Elastography Imaging Elastography Imaging Market by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Modality
- 7.4.5.1.2 Market size and forecast, by Application
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Modality
- 7.4.5.2.2 Market size and forecast, by Application
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 Australia
- 7.4.5.3.1 Market size and forecast, by Modality
- 7.4.5.3.2 Market size and forecast, by Application
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 India
- 7.4.5.4.1 Market size and forecast, by Modality
- 7.4.5.4.2 Market size and forecast, by Application
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Modality
- 7.4.5.5.2 Market size and forecast, by Application
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Modality
- 7.4.5.6.2 Market size and forecast, by Application
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Modality
- 7.5.2.1 LAMEA Ultrasound Elastography Imaging Elastography Imaging Market by Type
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Modality
- 7.5.5.1.2 Market size and forecast, by Application
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Modality
- 7.5.5.2.2 Market size and forecast, by Application
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Modality
- 7.5.5.3.2 Market size and forecast, by Application
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Modality
- 7.5.5.4.2 Market size and forecast, by Application
- 7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
CHAPTER 9: COMPANY PROFILES
- 9.1 Esaote SpA
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Shenzhen Mindray Bio-Medical Electronics Co
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Clarius Mobile Health
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Hitachi,Ltd
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Fujifilm Corporation
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Canon Inc
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Koninklijke Philips N.V.
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 GE
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Siemens Healthineers
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 Hologic Inc
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments